Biologics
Are Comparative Clinical Studies of Biologics Worth the Time and Cost?
FDA says a meta-analysis conducted by CDER scientists found that pharmacokinetic similarity studies provided useful information to descriptively evaluate the immunogenicity and safety of biologics, and that comparative clinical studies did not appear to be more definitive. In an online post, the agency says the scientists suggest that their